GcMAF neutralizes our immune system to defend itself. This allows the disease to progress uncontrolled. We use a small sample of healthy human serum to produce large amounts of new second-generation GcMAF in our specialized sterile laboratory, the Cell Processing Center (CPC). This highly active second-generation Gc-MAF is injected intramuscularly (IM) or subcutaneously (SC) into the patient, usually twice and in some cases 3 times a week. Over a matter of weeks and months, the immune system is strengthened through the activation of macrophages and begins to eradicate cancer cells, viruses and bacteria. In addition to GcMAF injections, another form of GcMAF manufactured from high-quality colostrum can be administered orally, in the gut and sublingually to activate macrophages in the lymphoid tissue.